(Q71214957)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689929%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

title

Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689929%20AND%20SRC:MED&resulttype=core&format=json

primary biliary cholangitis

17 October 2019

main subject

0 references

1 reference

Y Nishigaki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689929%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

H Ohnishi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689929%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

H Moriwaki

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689929%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

Y Muto

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689929%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

publication date

1 July 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689929%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

17 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689929%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689929%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689929%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

page(s)

1487-1493

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689929%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf02088577

17 October 2019

exact match

0 references

cites work

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

1 reference

12 December 2020

Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment

1 reference

12 December 2020

[Therapeutic effect of ursodeoxycholic acid on sulpyrine-induced intrahepatic cholestasis. A case report].

1 reference

12 December 2020

Clonal analysis of liver-derived T cells of patients with primary biliary cirrhosis

1 reference

12 December 2020

Natural killer-cell activity and the response to interferons alpha, beta, and gamma in patients with primary biliary cirrhosis

1 reference

12 December 2020

Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes

1 reference

12 December 2020

Adjuvant treatment with ursodeoxycholic acid reduces acute rejection after liver transplantation

1 reference

12 December 2020

Bile acid-induced inhibition of the lymphoproliferative response to phytohemagglutinin and pokeweed mitogen: an in vitro study.

1 reference

12 December 2020

Abnormal natural killer cytotoxicity in primary biliary cirrhosis: evidence for a functional deficiency of cytolytic effector cells

1 reference

12 December 2020

Immune dysfunction in primary biliary cirrhosis. II. Increased production of prostaglandin E

1 reference

12 December 2020

Prostaglandins from human T suppressor/cytotoxic cells modulate natural killer antibacterial activity

1 reference

12 December 2020

Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis

1 reference

12 December 2020

Homeostasis of the antibody response: immunoregulation by NK cells

1 reference

12 December 2020

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

1 reference

12 December 2020

Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis

1 reference

12 December 2020

Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy

1 reference

12 December 2020

Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment

1 reference

12 December 2020

Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients

1 reference

12 December 2020

Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver

1 reference

12 December 2020

Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse

1 reference

12 December 2020

Inhibition of human NK cell and LAK cell cytotoxicity and differentiation by PGE2.

1 reference

12 December 2020

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

12 December 2020

Ursodeoxycholic acid choleresis: relationship to biliary HCO-3 and effects of Na+-H+ exchange inhibitors

1 reference

12 December 2020

Ursodeoxycholic acid reduces acute rejection in heart allografted rats

1 reference

12 December 2020

Regulation of T cell proliferation by cloned interferon-alpha mediated by Leu-11b-positive cells.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02088577

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689929%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference